Intravascular Ultrasound (IVUS) Devices Market Forecasts to 2030 – Global Analysis By Product (IVUS Consoles/Imaging Systems, IVUS Catheters, IVUS Accessories, IVUS Software, IVUS Systems with FFR (Fractional Flow Reserve), IVUS Guidewires and Other Produ

Intravascular Ultrasound (IVUS) Devices Market Forecasts to 2030 – Global Analysis By Product (IVUS Consoles/Imaging Systems, IVUS Catheters, IVUS Accessories, IVUS Software, IVUS Systems with FFR (Fractional Flow Reserve), IVUS Guidewires and Other Products), Modality, Application, End User and By Geography

According to Stratistics MRC, the Global Intravascular Ultrasound (IVUS) Devices Market is accounted for $2.59 billion in 2024 and is expected to reach $4.52 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Intravascular ultrasound (IVUS) devices are medical instruments used during cardiac catheterization procedures to provide detailed images of blood vessel interiors. These devices utilize high-frequency sound waves emitted from a tiny probe attached to a catheter, which is inserted into the blood vessel. IVUS enables real-time visualization of the vessel walls, detecting plaque buildup, assessing vessel dimensions, and aiding in treatment planning. IVUS helps cardiologists make informed decisions regarding stenting, atherectomy, or other interventions to improve patient outcomes.

According to the Centers for Disease Control and Prevention (CDC), each year, about 805,000 Americans experience a heart attack; 605,000 of those heart attacks are the first ones and 200,000 occur in individuals who have already experienced one, and 1 in 5 heart attacks are silent.

Market Dynamics:

Driver:

Growing incidenceof cardiovascular diseases

IVUS devices play a crucial role in diagnosing and managing cardiovascular conditions by providing detailed imaging of blood vessels from within. IVUS technology enables precise assessment of plaque buildup and artery dimensions, aiding in accurate treatment decisions and improving patient outcomes. As healthcare providers increasingly prioritize early detection and intervention for cardiovascular diseases, the IVUS devices market continues to expand, driven by advancements in technology and rising awareness among healthcare professionals.

Restraint:

Inconsistent reimbursement policies

Inconsistent reimbursement policies in intravascular ultrasound (IVUS) devices arise due to varying regulations and criteria across different regions or healthcare systems. These inconsistencies create uncertainty for healthcare providers regarding reimbursement eligibility and rates, potentially deterring investment in IVUS technology. Providers may hesitate to adopt IVUS devices without clear financial incentives, limiting market expansion.

Opportunity:

Expanding healthcare infrastructure

Expanding healthcare infrastructure supports the growth of the intravascular ultrasound (IVUS) devices market by facilitating greater accessibility to advanced medical technologies. Improved healthcare facilities enable more hospitals and clinics to adopt IVUS devices, enhancing diagnostic capabilities and patient outcomes. Additionally, infrastructure expansion includes increased training opportunities for healthcare professionals, boosting the adoption rate of IVUS technology.

Threat:

Expensive IVUS equipment and procedures

The high cost of IVUS equipment and procedures hampers market growth primarily due to financial constraints faced by healthcare providers and patients. The initial investment required for purchasing IVUS equipment is substantial, limiting adoption, especially in resource-constrained regions. Moreover, the cost of IVUS procedures can be prohibitive for patients, reducing demand. These factors hinder market expansion by restricting access to advanced diagnostic capabilities and innovative treatment options.

Covid-19 Impact

The covid-19 pandemic significantly impacted the intravascular ultrasound (IVUS) devices market as healthcare resources were diverted to manage the crisis. Elective procedures, including those using IVUS, were postponed or cancelled, leading to a decline in device utilization and sales. However, as healthcare systems adapted and resumed elective surgeries, IVUS demand began recovering, driven by its essential role in cardiovascular diagnostics and treatment planning. The market is expected to stabilize as healthcare services gradually return to normalcy.

The IVUS catheters segment is expected to be the largest during the forecast period

The IVUS catheters segment is estimated to have a lucrative growth. IVUS catheters are medical devices used to visualize and assess the interior of blood vessels. They employ high-frequency sound waves to generate detailed images of vessel walls, providing clinicians with crucial insights into the extent of atherosclerosis, plaque morphology, and vessel dimensions. IVUS catheters play a pivotal role in guiding interventional procedures like angioplasty and stent placement, helping to optimize treatment outcomes by enabling precise assessment of vessel pathology directly from within the artery.

The peripheral vascular imaging segment is expected to have the highest CAGR during the forecast period

The peripheral vascular imaging segment is anticipated to witness the fastest CAGR growth during the forecast period. IVUS devices are instrumental in peripheral vascular imaging, facilitating high-resolution visualization of blood vessel interiors. These devices utilize sound waves to produce detailed cross-sectional images, aiding in the assessment of vessel morphology, plaque composition, and stenosis severity. IVUS devices offer real-time insights into vessel structure and pathology.

Region with largest share:

In the Asia-Pacific region, the Intravascular Ultrasound (IVUS) Devices market is experiencing growth driven by increasing cardiovascular disease prevalence, improving healthcare infrastructure, and rising healthcare expenditure. Countries like China, Japan, and India are key contributors to this growth due to their large patient populations and expanding healthcare access. Additionally, technological advancements and greater adoption of minimally invasive procedures are boosting IVUS device utilization.

Region with highest CAGR:

In North America, the Intravascular Ultrasound (IVUS) Devices market is well-established and characterized by advanced healthcare infrastructure, high adoption rates of innovative medical technologies, and significant investments in research and development. The United States leads in market share due to its large patient population, robust healthcare spending, and strong presence of key market players. IVUS devices are widely used in the diagnosis and treatment of cardiovascular diseases, driving market growth.

Key players in the market

Some of the key players profiled in the Intravascular Ultrasound (IVUS) Devices Market include Boston Scientific Corporation, Philips Healthcare, Abbott Laboratories, Terumo Corporation, Siemens Healthineers, Medtronic plc, GE Healthcare, Provisio Medical Inc., Avinger Inc., Infraredx Inc., Evident Vascular, Nipro Corporation, Koninklijke Philips N.V., Samsung Medison, Esaote SpA, Volcano Corporation

Key Developments:

In May 2024, Provisio Medical, Inc., announced the completion of the first commercial clinical cases utilizing the Provisio SLT intravascular ultrasound (IVUS) system.It gives rapid, novel, and extremely precise way to get the size and contour of vessels, which is critical for the appropriate treatment of a patient with chronic and limb threatening ischemia.

In October2023, Evident Vascular has launched IVUS transcatheterwith $35m in Series A financing from Vensana Capital for the development of an intravascular ultrasound (IVUS) platform. It is designed to capture images from inside blood vessels to assess vascular disease and guide interventional treatment.

Products Covered:
• IVUS Consoles/Imaging Systems
• IVUS Catheters
• IVUS Accessories
• IVUS Software
• IVUS Systems with FFR (Fractional Flow Reserve)
• IVUS Guidewires
• Other Products

Modalities Covered:
• Virtual Histology IVUS (VH-IVUS)
• Integrated Backscatter IVUS (IB-IVUS)
• Frequency Domain IVUS (FD-IVUS)
• Time Domain IVUS (TD-IVUS)
• Intracoronary Doppler IVUS
• Optical Coherence Tomography (OCT) IVUS
• Near-infrared Spectroscopy (NIRS) IVUS
• Other Modalities

Applications Covered:
• Coronary Imaging
• Peripheral Vascular Imaging
• Endovascular Imaging
• Transplant Imaging
• Other Applications

End Users Covered:
• Hospitals & Clinics
• Diagnostic Imaging Centers
• Ambulatory Surgical Centers (ASCs)
• Research Institutes
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements